Revenue up 34%, but profit fell 13% — execution lags ambition
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade B
Prior guidance on steady demand & capacity ramp being met in order form, but delivered quarter shows margin compression not anticipated.
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
Sharda is executing on multi-year strategy (lightweighting, exports, regulatory prep) with solid order books and customer engagement, but Q1 profit fell 13.4% despite 34% revenue growth, signaling margin pressure and execution drag. Near-term revenue inflection depends on SOPs in Q3-Q4; until then, margin recovery is key.
₹1011.1 Cr
Revenue · +33.7% YoY₹86.5 Cr
Reported PAT · −13.4% YoYCompressing
Margins · vs guidance: MixedDid the claims hold up?
Revenue growth 34% YoY, tracking addressable market of 8-10%
METRevenue ₹1,011.1 Cr, YoY growth 33.7%. Market growth 8-10% after excluding non-served segments (Japanese OEM, supplier fire impact).
Gross profit growth 8% reflects market growth; premium RM costs absorbed due to geopolitical disruption
METGross profit ₹203.9 Cr, YoY growth 8%. Management cited supplier fire impact + premium procurement as headwinds, offset partially by structural growth.
Lightweighting orders ramping on schedule; control arm & link market share 14% improving visibly this quarter
METControl arms/links ramping as scheduled. Market share still 14% (no interim updates; assessed annually). Visibility into FY27-28 order pipeline confirmed.
Export orders on track: US$10.7M annual (SOPs Q3-Q4 FY27 as guided) + US$58.5M lifetime
METTwo export orders totaling US$23.7M (prior start) + US$11.85M (Q3-Q4 FY27 start). Stated SOPs progressing per customer schedule. No revenue yet this quarter.
PAT ₹86.5 Cr reflects clean operating performance after geopolitical adjustments
OVERSTATEDPAT ₹86.5 Cr, down 13.4% YoY despite 34% revenue growth. Implies margin compression and/or JV profit headwinds, not offset by one-time costs.
Earnings quality
What changed since the last call
Export SOP timelines firmed
UpgradePrior call (Q4 FY26): SOPs expected Q3/Q4 FY27. Q1 FY27 call confirms on schedule; sampling/validation on track per customer requirement.
Guidance specificity reduced
DowngradePrior call projected 'full-year revenues' from FY27 orders; Q1 call hedges ('depends on customer schedules'), avoids numerical FY27 targets when pressed for INR100Cr+ projections.
Donghee partnership commercialization accelerated
UpgradeNow jointly showcasing products to OEMs; RFQs generated across multiple platforms. Prior was capability-building; now early-stage deal pipeline.
Margin profile flagged as pressure point
DowngradeQ1 gross profit growth (8%) lagged market growth (8-10%) due to one-time geopolitical costs. Analysts questioned whether this normalizes; management deferred full recovery to later qtrs.
The Q&A
Analysts pressed hard on why gross profit grew only 8% despite 34% revenue growth & strong industry backdrop. Management acknowledged supplier fire & premium costs but had to explain three times the mechanics of raw-material pass-through lags. Tone became defensive; no willingness to quantify export revenue impact ('difficult') when asked directly.
Export order pipeline — Preet, InCred AMC
PartialSOPs progressing per customer schedule; ramp depends on OEM pickup. Typically takes year or two to peak volumes. Numbers depend on customer schedules; difficult to project specific quarterly revenue.
Lightweighting market share — Preet, InCred AMC
PartialNo quarterly updates; market share assessed annually. With SOP visibility now, expect improvement by FY27 year-end. Number will be disclosed then.
Gross profit margin headwinds — Preet, InCred AMC
AnsweredCatalyst & steel prices pass through back-to-back to customers (no lag). Premium RM procurement & geopolitical labour costs were the headwind, already factored into 8% growth. Won't see catch-up next quarter due to regular indexing with lags.
Real underrecovery quantum — Sonal Gupta, HSBC Asset Management
PartialPremium freight on RM procurement only. Very difficult to quantify; 'number was not very significant.' Incurred in Apr-May due to geopolitics; stabilized by July.
Gross profit underperformance vs industry — Sonal Gupta, HSBC Asset Management
PartialThree growth drivers: (1) existing announced LW & export orders SOPs and ramp-up, (2) RFQ conversion, (3) organic industry growth. Extremely hopeful going forward.
Donghee TLA commercialization — Sonal Gupta, HSBC Asset Management
PartialCapability building & technology transfer ongoing. Jointly showcased Korean products to OEMs this quarter; generated RFQs across multiple platforms. Aspiration: ₹8000-9000Cr market in 5 years; mid-teen to high-teen market share. Still early; commercial timelines not yet firm.
Content change BS6.3 to BS7 — Viraj Kacharia, SiMPL
AnsweredWLTP: modest increase (calibration, thermal management, no redesign needed). BS7: not notified but Euro-7 benchmark shows hot-end, after-treatment, GPF, higher catalysts = material content uplift. CAFE III: all powertrains (EV, hybrid, CNG, flex-fuel) require emission systems; lightweighting also beneficiary.
Export emission pipeline colour — Viraj Kacharia, SiMPL
PartialOrders announced across CV emission, temperature-controlled tubes, genset, agri—not just emission. Organic growth, regulatory upgrades, China Plus One strategy all driving opportunities. RFQ pipeline diverse; no single trigger.
Premium 2-wheeler emission opportunity — Manprit Arora, Arora Wealth Advisors
AnsweredYes, analysed and found direct capability applicability. Strategic fit based on capability, customer requirement, and long-term visibility. Domestic focus for now; if OEM exports, that's their choice.
Purem JV inflection point — Manprit Arora, Arora Wealth Advisors
AnsweredNew program started Q4 FY26; ramping through FY27. JV unlocks advanced tech access & global landscape; limited PAT contribution (50% of PAT after deductions). Sector lucrative, unit economics good; evaluating deeper participation options. BS7 inflection continuous, not one-time.
Integrated muffler opportunity sizing — Manprit Arora, Arora Wealth Advisors
PartialSmall market, ₹60-100Cr total. Normal business development; not tracked separately. Content per vehicle not quantified.
Guidance
FY27 growth anchored on LW & export order SOPs, domestic OEM support
MediumNo numerical FY27 revenue target. Near-term constrained by SOP timelines (Q3-Q4); organic growth from order ramps & RFQ conversion.
EBITDA margin 10.2% this quarter; normalization of geopolitical costs expected Q2+
MediumPremium RM & labour costs absorbed in Q1; management expects stabilization in Apr-May onwards (geopolitics eased by July). No formal margin target.
Prior guidance FY27 capex ₹90-110 Cr maintained; modular capex linked to confirmed programs
HighChakan 3 ramping; Uttarakhand ₹20 Cr investment on track. Capex discipline emphasized; no aggressive buildout independent of customer orders.
Risks the call surfaced
Execution / SOP timing
HighNorth American export SOPs Q3-Q4 FY27 as guided, but actual revenue ramp depends on OEM platform pickup, which typically takes 1-2 years to peak. Analyst asked for ₹100-200Cr FY27-28 revenue contribution; management declined to quantify, citing customer schedule dependency.
Margin compression
HighQ1 gross profit grew only 8% vs 34% revenue, indicating either product mix shift, pass-through lag, or cost absorption. Supplier fire production impact + premium RM procurement costs cited. If lightweighting ramp is lower-margin than legacy emission, profit growth may lag revenue.
Customer concentration
MediumSupplier fire at one key customer resulted in production impact this quarter. Dependent on specific customer's supply chain resilience. Diversification underway (new geographies, Donghee products, premium 2-wheeler expansion) but early-stage.
Regulatory timing uncertainty
MediumBS7 not yet officially notified. CAFE III revised July 2026, moderates some benefits. If India adopts Euro-7 aligned standards, content uplift expected but timing/magnitude uncertain. OEM investment cycles dependent on final rules.
Technology partnership commercialization
MediumDonghee TLA generating RFQs this quarter, but no customer wins disclosed yet. Long R&D-to-revenue cycle typical for new platforms. Aspiration ₹8000-9000Cr market in 5 years with mid-teen to high-teen share not yet supported by booked revenue.
Management
Score 6/10. Management acknowledged one-time geopolitical costs & supplier fire impact honestly, but hedged on forward projections (declined to quantify export revenue 'difficult'). Took 3 clarifications to explain raw-material pass-through mechanics to analysts, suggesting either complex or evasive communication. Orders announced vs delivered: lightweighting & export wins moving from announcement to SOP, but revenue inflection still Q3+ away. Margin decline despite revenue beat raises questions on cost control & mix management. Track record on announced programs mixed (on schedule but operationally challenged).
1 · Q3 FY27
North American export order SOP; control arm ramp acceleration
2 · Q4 FY27
Second North American export SOP; Uttarakhand facility SOP phase 1
3 · FY28
Lightweighting market share expected to exceed 14%; Donghee TLA commercialization
Near-term revenue inflection depends on SOPs in Q3-Q4; until then, margin recovery is key.
Informational and educational content only. Not investment advice.